Collaborative cancer research agreement
The National Cancer Center, situated in Chuo-ku, Tokyo, Japan, and Shimadzu have reached a comprehensive collaborative research agreement that, it is hoped, will lead to the development of internationally leading, high-level, cutting-edge medical technologies that contribute to the suppression of cancer and the promotion of human health.
The National Cancer Center, situated in Chuo-ku, Tokyo, Japan, and Shimadzu have reached a comprehensive collaborative research agreement that, it is hoped, will lead to the development of internationally leading, high-level, cutting-edge medical technologies that contribute to the suppression of cancer and the promotion of human health. These include technological developments related to the realization of ultra-early cancer diagnoses, pharmacokinetic analysis for the achievement of a revolution in the drug discovery process, and medical treatments. According to the company, these developments will be accomplished through a fusion of the high-level cancer research techniques and clinical experience at the centre, and the company’s technologies in next-generation medical treatment fields.
The company has been pursuing R&D in the medical treatment fields of molecular imaging technology and biomarker searches, based on the fusion and application of its chromatography, mass spectrometry and other core analysis and measuring technology with medical imaging technology.
“Thus far,” said the company’s president Akira Nakamoto, ”the life sciences have been the core enterprise at Shimadzu. In the future, however, I would like to see the biomarker candidates discovered to‑date applied to ultra-early diagnosis; we believe this can be accomplished through the implementation of clinically useful medical science and a fusion of imaging diagnostics and molecular imaging, in conjunction with the NCC.”
For more information on the company visit www.shimadzu.com
This story originally appeared in The Column. Click here to view that issue.
Investigating the Protective Effects of Frankincense Oil on Wound Healing with GC–MS
April 2nd 2025Frankincense essential oil is known for its anti-inflammatory, antioxidant, and therapeutic properties. A recent study investigated the protective effects of the oil in an excision wound model in rats, focusing on oxidative stress reduction, inflammatory cytokine modulation, and caspase-3 regulation; chemical composition of the oil was analyzed using gas chromatography–mass spectrometry (GC–MS).
Evaluating Natural Preservatives for Meat Products with Gas and Liquid Chromatography
April 1st 2025A study in Food Science & Nutrition evaluated the antioxidant and preservative effects of Epilobium angustifolium extract on beef burgers, finding that the extract influenced physicochemical properties, color stability, and lipid oxidation, with higher concentrations showing a prooxidant effect.
Rethinking Chromatography Workflows with AI and Machine Learning
April 1st 2025Interest in applying artificial intelligence (AI) and machine learning (ML) to chromatography is greater than ever. In this article, we discuss data-related barriers to accomplishing this goal and how rethinking chromatography data systems can overcome them.
